149096-35-5

Basic information

• Product Name: 1H-Imidazole-4-carboxylicacid,1-propyl-(9CI)
• Synonyms: 1H-Imidazole-4-carboxylicacid,1-propyl-(9CI);1H-Imidazole-4-carboxylicacid, 1-propyl-;1-propyl-1H-iMidazole-4-carboxylic acid
• CAS NO: 149096-35-5
• Molecular Formula: C7H10N2O2
• Molecular Weight: 154.168
• Product Categories: CARBOXYLICACID;GLYCINESCAFFOLD
• Mol File: 149096-35-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1H-Imidazole-4-carboxylicacid,1-propyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Imidazole-4-carboxylicacid,1-propyl-(9CI)(149096-35-5)
• EPA Substance Registry System: 1H-Imidazole-4-carboxylicacid,1-propyl-(9CI)(149096-35-5)

Safety Data

• Hazardous Substances Data: 149096-35-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
1H-Imidazole-4-carboxylic acid, 1-propyl-(9CI) serves as a crucial building block in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure allows for the creation of new compounds with potential therapeutic or pesticidal properties, contributing to the development of innovative treatments and products in these industries.
Used in Medicinal Chemistry Research:
As a compound with potential biological activities, 1H-Imidazole-4-carboxylic acid, 1-propyl-(9CI) is utilized in medicinal chemistry research to explore its interactions with biological targets. This research aims to uncover its potential as a therapeutic agent or a lead compound for the development of new drugs.
Used in Drug Discovery:
1H-Imidazole-4-carboxylicacid,1-propyl-(9CI)'s presence in drug discovery processes is significant, as it may possess properties that can be harnessed to create novel medications. Researchers investigate its pharmacological profile, including its binding affinity, selectivity, and potential side effects, to assess its suitability as a drug candidate.

Upstream product

• 149096-32-2 methyl-1-prpylimidazole-4-carboxylate 

Downstream Products

• 149096-32-2 methyl-1-prpylimidazole-4-carboxylate 

Relevant articles and documents

3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF

The present invention provides KDM5 inhibitor. The compound disclosed herein represented by the general formula (I) : wherein all symbols have the same meanings as the definitions described in the specification; or a salt thereof is useful as a prophylact

INHIBITORS OF AKT ACTIVITY

The instant invention provides for substituted naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.

ALKYLATION OF METHYL IMIDAZOLE-4(5)-CARBOXYLATE WITH 1-BROMOPROPANE AND ETHYL BENZENESULFONATE

Methyl 1-propylimidazole-4- and 1-propylimidazole-5-carboxylates were obtained in the ratio of ca.2:1 by alkylation of methyl imidazole-4(5)-carboxylate with 1-bromopropane in an alkaline medium.Reaction of methyl imidazole-4(5)-carboxylate with ethyl benzenesulfonate gave a 1:1 mixture of methyl 1-ethylimidazole-4- and 1-ethylimidazole-5-carboxylates.The regioselectivity of the alkylation may be due to the fact that the reaction is entropy-controlled.